Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.
This combination of email and password didn't match our records. Your account might not be activated. If so, please click on the link we sent you via email. You can also request a password reset or a new activation email using the links below.
MORE FILTERS
DGAP-News: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Investor Conferences in December 24.11.2020 / 12:30 The issuer is solely responsible for the content of this announcement. Immunic, Inc. to Participate in Investor Conferences in December NEW YORK, November 24, 2020 - Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced management's participation in the following investor conferences...
Экономика России с поправкой на сезонность в октябре осталась примерно на том же уровне, что и месяцем ранее. Это неплохой результат с учетом того, что в стране началась вторая волна эпидемии коронавируса и в некоторых российских регионах уже вводятся карантинные ограничения. Вероятно, этот фактор будет сдерживать восстановление экономики в 4К20. Впрочем, с учетом хорошей динамики ВВП за 3К20 (годовое снижение этого показателя составило всего 3,6% после падения на 8,0% в 2К20), можно предположить, что по итогам 2020 года экономический спад составит 3,5-4,0%.> Разнонаправленная динамика в базов...
Martela Oyj: Managers' transactions Martela Oyj: Managers' transactions Person subject to the notification requirement Name: Vepsäläinen, Anni Position: Member of the Board Issuer: Martela Oyj LEI: 743700M4EIEVD61PNN55 Notification type: INITIAL NOTIFICATION Reference number: 743700M4EIEVD61PNN55_20201124082826_2 Transaction date: 2020-11-19 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009900385 Nature of the transaction: ACQUISITION Transaction details (1): Volume: 2,000 Unit price: 2.55000 EUR Aggregated transactions (1): Volume: 2,000 Volume weighted average pri...
MediciNova Announces Initiation of Master Virus Seed Stock Production for its Intranasal COVID-19 Vaccine using BC-PIV Vector Technology LA JOLLA, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that Good Manufacturing Practice (GMP)-based Master Virus Seed Stock (MVSS) production of its novel intranasal SARS-CoV-2 vaccine for COVID-19, using BC-PIV technology, has been initiated at Millipore Sigma BioReliance Service...
SpringWorks Therapeutics to Participate in the Evercore ISI HealthCONx Conference STAMFORD, Conn., Nov. 24, 2020 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that Saqib Islam, Chief Executive Officer, will participate in a Fireside Chat at the 3rd Annual Evercore ISI HealthCONx Conference, taking place virtually on Wednesday, December 2, 2020 at 12:35 p.m. ET. A video webcast will be available on the “Events & Pr...
Martela Oyj: Johdon liiketoimet Martela Oyj: Johdon liiketoimet Ilmoitusvelvollinen Nimi: Vepsäläinen, Anni Asema: Hallituksen jäsen Liikkeeseenlaskija: Martela Oyj LEI: 743700M4EIEVD61PNN55 Ilmoituksen luonne: ENSIMMÄINEN ILMOITUS Viitenumero: 743700M4EIEVD61PNN55_20201124082826_2 Liiketoimen päivämäärä: 2020-11-19 Kauppapaikka: NASDAQ HELSINKI LTD (XHEL) Instrumenttityyppi: OSAKE ISIN: FI0009900385 Liiketoimen luonne: HANKINTA Liiketoimien yksityiskohtaiset tiedot (1): Volyymi: 2 000 Yksikköhinta: 2,55000 EUR Liiketoimien yhdistetyt tiedot (1): Volyymi: 2 000 Keskihinta: 2,55000 EU...
Etrion Presents at Fearnley Securites Annual Renewables Seminar 2020 GENEVA, Switzerland, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, announces that the Company’s Chief Executive Officer, Marco A. Northland, will be presenting at the Fearnley Securites Annual Renewables Seminar on Tuesday, November 24, 2020 at 2:10 pm Central European Time. The presentation will be live online and a copy of the material will be available on Etrion’s website shortly afterwards. About EtrionEtrion Corporation is...
A director at Alstria Office AG bought 10,379 shares at 13.577EUR and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of ...
A director at Oyj Ahola Transport Abp sold 267,900 shares at 1.600EUR and the significance rating of the trade was 84/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names...
Copenhagen Capital A/S – Periodemeddelelse for 3. kvartal 2020 Copenhagen Capital A/S afgiver periodemeddelelse for 3. kvartal 2020. Selskabet offentliggør ikke finansiel information som en del af periodemeddelelser. Driften af ejendommene forløber som forventet. Selskabet har i perioden blandt andet arbejdet med: Ombygningen af ejendommen Læderstræde 11A og 11B, 1201 København K går som planlagt. De nye lejligheder forventes færdige til udlejning i 1. kvartal 2021. Opførslen af 41 ungdomsboliger og 1 erhvervslejemål på grunden Frederikssundsvej 11, 2400 København N under totalentrepr...
A director at Next Capital Public Company Ltd sold 400,000 shares at 5.050THB and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. T...
KPN has issued headline guidance and plans ahead of this afternoon’s more detailed CMD.
Undersøgelse af muligheden for udstedelse af Senior Non-Preferred Selskabsmeddelelse nr. 25/2020 Holbæk, den 24. november 2020 Undersøgelse af muligheden for udstedelse af Senior Non-Preferred Sparekassen Sjælland-Fyn A/S har, som en del af den løbende proces med at optimere kapitalstrukturen, besluttet at undersøge muligheden for udstedelse af ikke-foranstillet seniorgæld (Senior Non-Preferred). I tilfælde af en tilfredsstillende interesse i markedet forventes udstedelsen at finde sted inden udgangen af 2020. Med venlig hilsen Lars Petersson ...
De la presentación realizada hoy en su Investor Day destacamos los siguientes mensajes: Estimaciones 2023: Reiteró su objetivo de doblar los ingresos operativos y multiplicar por 2,5x el EBITDA recurrente en 2023 vs 2018 (>600 M euros en ventas y 160 M euros en EBITDA ex I+D) en línea con nuestras estimaciones (consenso no disponible). Fabricación a terceros (~22% ventas 2020 BS(e)): Confirmó que espera crecimiento entre el +20%-25% en 2020 (vs +35% BS(e)) y entre un +10% y un +15% en 2021 (vs +6% BS(e)) incluyendo actividades relacionadas con Moderna y excluyendo la producción de su vacu...
A director at Thonburi Healthcare Group Public Company Limited bought 2,050,000 shares at 20.711THB and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted un...
A director at Cmc JSC sold 3,999,088 shares at 0.000VND and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board mem...
EQS Group-News: MetrioPharm AG / Key word(s): Scientific publication/Study MetrioPharm AG: COVID-19 Therapeutic Agent: MetrioPharm Prepares to Conduct a Phase II Clinical Trial 24.11.2020 / 12:05 - Drug Candidate exerts strong SARS-CoV-2 specific antiviral properties in the in vitro infection test - Preclinical data were published in the International Journal of Molecular Science - MP1032 shows an outstanding safety profile in previous clinical trials Zurich, November 24, 2020. MetrioPharm AG, a pharmaceutical company developing drugs for chronic inflammatory diseases, a...
Save your current filters as a new Interest
Would you like to receive real-time email alerts when a new report is published under this interest?
These search results will show up under 'Saved searches' in the left panel
Would you like to receive real-time email when a new report matches this search?
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
